Neurology News
Latest developments in neurological diseases
Migraine Prevalence Study in Turkey: 1 in 5 Women Affected
A comprehensive study by the Turkish Neurological Society across 15 provinces revealed that migraine prevalence in Turkey is higher than expected.
AI-Powered Seizure Prediction in Epilepsy: New Wearable Device
MIT inventors have developed a new AI-powered wearable device that can predict epileptic seizures an average of 45 minutes in advance.
Daily 30-Minute Walking Proven to Reduce Dementia Risk by 40%
A large-scale study published in The Lancet confirmed that regular physical activity significantly reduces dementia risk.
Importance of Early Treatment in Childhood Epilepsy: New Guideline
ILAE's new guideline emphasizes that early and aggressive treatment in childhood epilepsy improves long-term outcomes.
Gut-Brain Axis in Neurological Diseases: New Evidence for Microbiome Therapy
A review in Nature Neuroscience shows gut microbiome plays a role in multiple neurological diseases including migraine, epilepsy and dementia.
Lecanemab Receives Approval in Turkey: Early Stage Alzheimer Treatment
Amyloid plaque-clearing antibody therapy lecanemab has been approved by TITCK for early-stage Alzheimer's disease.
Brain Mechanism of Migraine Aura Imaged for First Time
Harvard and MIT researchers have successfully imaged how migraine aura spreads in the brain for the first time. Findings open the door to new treatment targets.
Turkey Neurology Week 2026: Importance of Awareness
Turkish Neurological Society launched a free neurological examination campaign nationwide as part of 2026 Neurology Week.
Alzheimer Blood Test Opens Breakthrough in Early Diagnosis
A newly developed blood test can detect Alzheimer's disease up to 15 years before symptoms appear by measuring phosphorylated tau 217 protein.
FDA Approves New CGRP Antagonist Drug for Chronic Migraine
The FDA has approved a new generation CGRP receptor antagonist for chronic migraine treatment. The drug promises hope for patients experiencing 15 or more migraine days per month.
2026 European Headache Congress: Key Findings
New studies presented at the Barcelona congress confirmed the efficacy of neural stimulation methods in migraine treatment.
Effect of Cognitive Games on Mild Cognitive Impairment: Meta-Analysis Results
A meta-analysis covering 42 studies revealed that digital cognitive exercises improve attention and working memory in mild cognitive impairment.
Next-Gen Neurostimulation Device Effective in Three Diseases
Programmable neurostimulation device shows successful results in clinical trials for migraine, epilepsy and mild cognitive impairment.
EMA Approves Cenobamate for Drug-Resistant Epilepsy
The European Medicines Agency has approved cenobamate for the treatment of drug-resistant focal epilepsy.